2009 version of "Medical Insurance Catalog" announced before and after some pharmaceutical companies raided price increases,Finally ushered in price control of the National Development and Reform Commission。 
    July 1,The National Development and Reform Commission issued the "Notice on the Investigation of Factory Price Price",The scope of this survey is the new drug and some priced drugs for medical insurance,A total of 896 varieties。
    At the end of November 2009,New version of the National Medical Insurance Catalog announced,Among them, 226 varieties are added in Western medicine,234 new varieties in Chinese medicine。Expansion of medical insurance medication,Some special effects、Exclusive drugs enter the reimbursement scope。
    After issuing a notice under the National Development and Reform Commission,July 9,The Beijing Development and Reform Commission quickly issued a notice,It will be right、Shuanghe Pharmaceutical、Beijing Nova、101 varieties of 101 varieties such as Sanofian Wante's 101 varieties Implementation product leaving factory price survey。
    National and local Development and Reform Commission this round of price survey,The first step is the enterprise self -check,Subsequent provincial My stake betting appMy stake betting appprice authorities for spot checks。
    Beijing survey 52 companies to leave the factory price
    This time the factory price survey was received,Tongrentang involved an Angong Palace Pressure Pill、Eleven varieties including Lotus Pills,Shuanghe Pharmaceuticals involved heavier syrup、Shu Huening injection、13 varieties such as animals and lung surface active substances,Foreign -funded brand Nova Pharmaceuticals with Bena Puli、Flosin、Naglena、Barloblumanohamine、Terbim Fen、Detabard、7 varieties such as Salutan。
    An analyst of a pharmaceutical industry revealed,"The varieties surveyed by Tongrentang are all new medical insurance varieties,Considering the high -quality product of Tongrentang,The factory price survey or has little impact on them。”
    "What has a greater influence on Tongrentang is the high -quality high -quality price of Chinese medicine now enjoyed by Tongrentang,After 4 years of transition period, it may be transformed into different prices,At that time, Tongrentang's products are in the face of homogeneous competition,No advantage。"The medical analysis person said。
    Novartis 7 varieties,Telbipidin and bisircles of dihequan are new medical insurance directory varieties,Beninpby、Flosin、Naglena、Terbim Fen、Tshadan, etc., there are varieties of medical insurance directory。
    Tabil is designated as the main drug of hepatitis B in Nuohua,It was suspected of dying patients due to adverse drug reactions,Currently entering judicial procedures。Barcelistate diolinine, also known as "Fugulin",It is the main external medicine sold by Novartis in China。
    Except Novartis,Foreign -funded brand Sanofi also has a pharmaceutical "Remici" will involve the factory price survey。
    July 13,Song Xinrong, the person in charge of the Beijing Nuohua Pharmaceutical Public Relations Department, told reporters,"I don't know if the Beijing Municipal Development and Reform Commission has already investigated the factory price of enterprise products,As long as they ask for providing declaration information,We will cooperate。”
    "Many major varieties stake betting appMy stake betting appof Novartis have to conduct factory price surveys,This shows that the product pricing is still high when entering the medical insurance directory when entering the medical insurance directory,This investigation of their ex -factory price,It is difficult to say if it can be reduced to the price。"" A domestic pharmaceutical company person said。
    A person from Zhejiang Pharmaceutical Company said,"Surveying out of factory prices has little impact on foreign -funded enterprises,Their winning price is the factory price,If you really want to check them,Checking their cost may have problems,But this survey did not ask to check the cost price。”
    How to investigate?
    In the survey list released by the National Development and Reform Commission,The factory price investigation involved 896 varieties involved in 927 companies。
    This newspaper learned,The year of the survey is 2009,The survey content includes the price of drugs from the factory,Basic situations of the financial management of manufacturers。
    This survey will be implemented by the provincial price authorities,Unified deployment in the provincial level。The survey should be inspected on the spot to check the relevant financial accounts、Random drawing original voucher and other survey methods。
    This survey requires that the manufacturer is not only truthful、Accurately fill in the "Investigation Form for the Basic Situation of Production Enterprises and Drugs"、"Survey Form for Drugs Factory Price",It also needs to provide drug production approval、New drug certificate、Patent Certificate and other documents,and sales contract or agreement。
    Different from previous surveys is,This time it clearly requires investigating the annual accounting final account and audit report of the company,Drug sales details、Accounting voucher、Tax invoice, etc.。
    To get the real factory price of the medicine,requirements of the National Development and Reform Commission,"A verifying the sales of drugs for survey、Sales income、The highest value of the factory price (excluding tax)、minimum value、average。Check the sales details,Stake Sports Bettingstake sports betting appIf necessary, you can check the ’ Staying、Financial month report、Annual reports to verify the number of sales。”
    "Spring check a certain number of original sales vouchers and sales invoices,A verification of the factory price。Copy contains the highest price、The lowest price and the top 10 sales invoices of the number of single sales。”
    "Sky price asparagus tablets" incident,Let the content of the investigation of this Development and Reform Commission's workless regulations,Reflect that the National Development and Reform Commission must "move the truth" for exporting prices。
    but,Analysis of a person in Zhejiang companies,"The fact that the Dharma and Reform Commission investigated the drug out of the factory should not be so severe,After all, the face involved is wide,and mainly commissioned the price bureaus of various places to do。”
    Vice President of China Medical Enterprise Management Association、Deputy General Manager of Kyushu Niu Zhenggan believes,It is difficult to investigate the factory price of drugs now,Unless "the chairman of the enterprise goes to the government department as an official,Officials who control the price of government departments to the enterprise to do the general manager,(This is the case) These costs can be made clear,Otherwise, I can't figure it out "。
    "The current drug price survey is undergoing the company's self -examination stage,However, the company's own self -check is relatively loose;,You can master the actual ex -factory price of the manufacturer。"The above -mentioned business person said。
    The National Development and Reform Commission announced the draft of comments on the "Administrative Measures for the Price of Drugs"。
    In Article 25 of the Draft for Soliciting Opinions,"Government guidance prices and drugs that have been listed on sale,Government price authorities can concentrate on government guidance price every 2-3 years。Where,Drugs treated with patented drugs and patented drugs,Adjust the cycle with 3 years,The decline is generally not less than 6%; after the protection period is over,Government guidance price is generally not less than 15%。”
    In order to promote this Stake Sports Bettingdrug outlet price survey,The National Development and Reform Commission stake online sports bettingwill train the drug price investigators in various provinces,"The Drug Price Review Center of the Development and Reform Commission will train these people,Our Zhejiang Development and Reform Commission has more than 10 people here。"People in the pharmaceutical community in Zhejiang Province said。